Publications by authors named "L Robichaud"
Article Synopsis
- - A new measure has been created to evaluate the Quality of Life (QoL) for young people aged 8-18 with advanced cancer, engaging young research partners in its development.
- - The research followed a four-phase plan that included creating and testing the questionnaire for clarity, assessing its social validity, and refining it based on feedback from 12 young patients.
- - The final versions of the questionnaires address key QoL domains and aim to meet the specific needs of young cancer patients and their families, receiving positive feedback during the evaluation process.
Article Synopsis
- Pediatric Brain Tumor Survivors (PBTS) face challenges in social, academic, and employment settings after treatment, often not utilizing available support services.
- A study with 68 participants, including survivors and parents, aimed to confirm and prioritize solutions to help PBTS reintegrate into daily activities post-treatment.
- Key priorities identified include the need for health professionals to provide evaluation, counseling, and ongoing follow-up, as well as addressing the challenges of implementing recommendations in educational and workplace environments.
Objective The objective of this study is to identify the top five most influential papers published on focused assessment with sonography in trauma (FAST) and the top five most influential papers on the extended FAST (E-FAST) in adult patients. Methods An expert panel was recruited from the Canadian Association of Emergency Physicians (CAEP) Emergency Ultrasound Committee and the Canadian Ultrasound Fellowship Collaborative. These experts are ultrasound fellowship-trained or equivalent, are involved with point-of-care ultrasound (POCUS) research and scholarship, and are leaders in both the POCUS program at their local site and within the national Canadian POCUS community.
View Article and Find Full Text PDFIntroduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a poorly understood side effect of many antineoplastic agents. Patients may experience sensory, motor and autonomic symptoms, negatively impacting quality of life. A gold-standard assessment methodology has yet to be determined, limiting efforts to identify effective agents to prevent or treat CIPN.
View Article and Find Full Text PDFBy 2025, 34 million people worldwide will be living with Alzheimer's disease or another form of dementia (i.e., neurocognitive disorders).
View Article and Find Full Text PDF